Congratulations to Dr. Ryan Brinkman on receiving a 5-year NSERC Discovery Grant for his proposal entitled "Automated analysis of high dimensional flow cytometry data" and Dr. Peter Stirling on a 5-year NSERC Discovery Grant and 3-year Discovery Accelerator Supplement (DAS) for his proposal entitled “Nuclear protein quality control mechanisms during genotoxic stress”.
Congratulations to Dr. Florian Kuchenbauer (Kuchenbauer Lab), who has been awarded a 2020 Canada Innovation Fund (CFI)/BC Knowledge Development Fund (BCKDF) John R. Evans Leaders Fund (JELF) grant for his proposal “Exploring mitochondrial function as therapeutic target in acute myeloid leukemia and multiple myeloma".
Afsaneh Mojtabanezhad Shariatpanahi awarded Echoridge Educational Foundation Scholarship in Continuing Education of Stem Cell Transplant Research & Development
Congratulations to Afsaneh Mojtabanezhad Shariatpanahi (Kuchenbauer Lab) who has been awarded an Echoridge Educational Foundation Scholarship in Continuing Education of Stem Cell Transplant Research & Development for her project entitled “Elucidating the molecular mechanism of high-risk multiple myeloma”.
Louis-Alexandre Fournier (Stirling Lab) awarded CIHR Doctoral Award (Frederick Banting and Charles Best Canada Graduate Scholarship)
Congratulations to Louis-Alexandre Fournier (Stirling Lab) who has been awarded a CIHR Doctoral Award (Frederick Banting and Charles Best Canada Graduate Scholarship) for his project entitled “Investigating the role of ARID1A loss in cancer and its effects on R-loop accumulation and genome instability”.
Drs. Florian Kuchenbauer, Robert Britton, David Vocadlo and Matthew Nodwell awarded Canadian Cancer Society Innovation Grant
Congratulations to Dr. Florian Kuchenbauer (Kuchenbauer Lab) who recently has been awarded a two-year Canadian Cancer Society Innovation Grant as part of a research team consisted of investigators from Simon Fraser University (Dr. Robert Britton, the Lead PI, and Drs. David Vocadlo and Matthew Nodwell) for their proposal entitled “Small molecule inhibitors of O-GlcNAc transferase: validation of a new anticancer target”.
Elizabeth Bulaeva (Eaves Lab) successfully defended her PhD thesis entitled “Analysis of a de novo c-MYC-induced model of human Acute Myeloid Leukemia”.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.